Profile
Emily Doyle served as Vice President-Global Human Resources at Globus Medical, Inc. from 2018 to 2019.
Prior to that, she was Head-Human Resources at AstraZeneca AB from 2015 to 2017.
She also held the position of Senior Vice President-Global Human Resources at Strongbridge Biopharma Plc.
Ms. Doyle received an undergraduate degree from Metropolitan State University of Denver.
Former positions of Emily Doyle
| Companies | Position | End |
|---|---|---|
| GLOBUS MEDICAL, INC. | Human Resources Officer | 01/03/2019 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Human Resources Officer | 01/01/2017 |
| STRONGBRIDGE BIOPHARMA | Human Resources Officer | - |
Training of Emily Doyle
| Metropolitan State University of Denver | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GLOBUS MEDICAL, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Emily Doyle
